Tomoko Watanabe

Tomoko Watanabe

Auto-generated profile, based on publicly available information

Tomoko Watanabe

Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8566, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
PDF file
TWTakao Watanabe
Takao Watanabe
HKHiroyuki Kusuhara
Hiroyuki Kusuhara
TWTomoko Watanabe
Tomoko Watanabe
YDYasuyuki Debori
Yasuyuki Debori
KMKazuya Maeda
Kazuya Maeda
YSYuichi Sugiyama
Yuichi Sugiyama
The present study investigated prediction of the overall renal tubular secretion and hepatic clearances of anionic drugs based on in vitro transport studies. The saturable uptake of eight drugs, most of which were OAT3 substrates (rosuvastatin, pravastatin, pitavastatin, valsartan, olmesartan, trichlormethiazide, p-aminohippurate, and benzylpenicillin) by freshly prepared human kidney slices underestimated the overall intrinsic clearance of the tubular secretion; therefore, a scaling factor of 10 was required for in vitro-in vivo extrapolation. We examined the effect of gemfibrozil and its metabolites, gemfibrozil glucuronide and the carboxylic metabolite, gemfibrozil M3, on pravastatin uptake by human kidney slices. The inhibition study using human kidney slices suggests that OAT3 plays a predominant role in the renal uptake of pravastatin. Comparison of unbound concentrations and Ki values (1.5, 9.1, and 4.0 μM, for gemfibrozil, gemfibrozil glucuronide, and gemfibrozil M3, respectively) suggests that the mechanism of the interaction is due mainly to inhibition by gemfibrozil and gemfibrozil glucuronide. Furthermore, extrapolation of saturable uptake by cryopreserved human hepatocytes predicts clearance comparable with the observed hepatic clearance although fluvastatin and rosuvastatin required a scaling factor of 11 and 6.9, respectively. This study suggests that in vitro uptake assays using human kidney slices and hepatocytes provide a good prediction of the overall tubular secretion and hepatic clearances of anionic drugs and renal drug-drug interactions. It is also recommended that in vitro-in vivo extrapolation be performed in animals to obtain more reliable prediction.

15 October 2018 in Development
Verified
Journal Article
Closed access
PDF file
TWTomoko Watanabe
Tomoko Watanabe
TYTakayoshi Yamamoto
Takayoshi Yamamoto
KTKohei Tsukano
Kohei Tsukano
SHSayuki Hirano
Sayuki Hirano
AHAyumi Horikawa
Ayumi Horikawa
Tatsuo MichiueTatsuo Michiue
Tatsuo Michiue
The pre-placodal ectoderm (PPE) is a specialized ectodermal region which gives rise to the sensory organs and other systems. The PPE is induced from the neural plate border (NPB) during neurulation, but the molecular mechanism of PPE formation is not fully understood. In this study, we examined the role of a newly identified PPE gene, Fam46a, during embryogenesis. Fam46a contains a nucleoside triphosphate (NTP) transferase domain, but its function in early development was previously unclear. We showed that Fam46a is expressed in the PPE in Xenopus embryos, and Fam46a knockdown induces the abnormalities in the eye formation and the body color. At the neurula stage, Fam46a upregulates the expression of PPE genes and inhibits neural crest (NC) formation. We also showed that Fam46a physically interacts with Smad1/Smad4 and positively regulates BMP signaling. From these results, we concluded that Fam46a is required for PPE formation via the positive regulation of BMP signaling. Our study provides a new mechanism of ectodermal patterning via cell-autonomous regulation of BMP signaling in the PPE.

18 January 2006 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
TWT. Watanabe
T. Watanabe
YIY. Inagaki
Y. Inagaki
YIY. Ishibe
Y. Ishibe

19 May 2022 in Developmental Biology
Verified
Journal Article
Closed access
KTKohei Tsukano
Kohei Tsukano
TYTakayoshi Yamamoto
Takayoshi Yamamoto
TWTomoko Watanabe
Tomoko Watanabe
Tatsuo MichiueTatsuo Michiue
Tatsuo Michiue

6 August 2015 in Genesis
Verified
Journal Article
Closed access
PDF file
TWTomoko Watanabe
Tomoko Watanabe
YKYuna Kanai
Yuna Kanai
SMShinya Matsukawa
Shinya Matsukawa
Tatsuo MichiueTatsuo Michiue
Tatsuo Michiue

1 August 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TWTomoko Watanabe
Tomoko Watanabe
SSSayoko Saito
Sayoko Saito
KHKeiko Hiemori
Keiko Hiemori
KKKayo Kiyoi
Kayo Kiyoi
SMShuuji Mawaribuchi
Shuuji Mawaribuchi
HTHiroaki Tateno
Hiroaki Tateno